1. Home
  2. Media
  3. News
  4. Bioiberica to present the results of the Arthrosischip Project, a DNA-based test that predicts the evolution of knee osteoarthritis using a simple saliva sample

Bioiberica to present the results of the Arthrosischip Project, a DNA-based test that predicts the evolution of knee osteoarthritis using a simple saliva sample

19 Apr 2012
Healthcare

• This new tool will allow for the personalization of osteoarthritis treatments, and will reduce the need for prosthetic surgery.• The study’s results will be presented at the World Congress on Osteoarthritis, to be held in Barcelona, Spain, on April 25-29, 2012

Barcelona, April 19, 2012. Bioiberica Farma will present the results of its Arthrosischip Project during the World Congress on Osteoarthritis. Arthrosischip is a genetic, DNA microarray-based test that identifies patients with genetic predisposition to rapid knee osteoarthritis progression. This test, which requires only a saliva sample, will allow for a more personalized treatment of osteoarthritis patients, as well as reduce the need for prosthetic surgery. This study has involved more than 200 patients coming from 32 different Spanish hospitals, over a period of four years.

The presentation will take place next Wednesday, April 25th, at 10:00 am, during the press conference inaugurating the World Congress on Osteoarthritis. This year’s edition will focus on the latest advances in osteoarthritis research, and will be hosted by the Sociedad Española de Reumatología.

Besides, during OARSI 2012 Bioiberica Farma will host two specialized symposiums. The first one, to be held on Thursday, April 26th, at 11:00 am, will deal with personalized medicine in the diagnosis and treatment of osteoarthritis. Among other subjects, osteoarthritis bio markers will be discussed, and Bioiberica will present the results of its Arthrosischip project to the scientific community. 

The second one, to be held on Friday, April 27th, at 12:20 am, will focus on the impact of synovitis in osteoarthritis progression, and the mechanism of action of chondroitin sulphate in inflammatory processes.

Below you will find the symposium programme listing the experts’ panel of OARSI 2012 -they will be at your disposal for in-depth interviews. During the coming days, we will issue more detailed information in relation to the papers to be read at the congress.

Press Conference. World Congress OARSI 2012 and presentation of results of the Arthrosischip Project. 

Day: Wednesday, April 25th
Place: Hotel AC Barcelona, Sant Gervasi Conference Room (14th floor)
Hour: 10:00 am

List of Lecturers:
- Dr. Eduardo Úcar, president of the Sociedad Española de Reumatología
- Dr. Linda Sandell, president of OARSI
- Dr. Josep Vergés, Medical and scientific director of Bioiberica, member of the organizing committee of the OARSI congress
- Dr. Blanco, Director, Instituto de Investigación Biomédica de la Coruña (INIBIC) and Chair of the Research and Training Committee of the OARSI

Symposiums hosted by Bioiberica Farma
Personalized medicine for osteoarthritis patients: Promise or reality?

Day: Thursday, April 26
Place: Barcelona International Convention Centre
Hour: 11:00 am

Impact of synovitis in the development of osteoarthritis
Day: Friday, April 27
Place: Barcelona International Convention Centre
Hour: 12:30 pm

For further information, please contact. 
Alba Soler
Communications Manager, Bioiberica Farma
+34 682 040 776 or +34 93 490 49 08

Aina Mauri
93 217 22 17